Inter-individual variation of inflammatory markers of cardiovascular risks and diseases

References

1. Poulter N. Coronary heart disease is a multifactorial disease. Am J Hypertens 1999; 12: 92S−5S. 10.1016/S0895-7061(99)00163-6Search in Google Scholar

2. Hegele RA. Gene-environment interactions in atherosclerosis. Mol Cell Biochem 1992; 113: 177–86. 10.1007/BF00231537Search in Google Scholar

3. Hansson GK, Jonasson L, Seifert PS, Stemme S. Immune mechanisms in atherosclerosis. Arteriosclerosis 1989; 9: 567–78. 10.1161/01.ATV.9.5.567Search in Google Scholar

4. Tedgui A, Mallat Z. Mécanismes inflammatoires et anti-inflammatoires dans la paroi vasculaire. In: Pinet F, Babuty D, Carrier L, Duperray A, Grynberg A, Loirand G, Samuel JL, editors. Biologie et pathologie du coeur et des vaisseaux. Paris: Medecine-Science/Flammarion, 2002:395–407. Search in Google Scholar

5. Balbay Y, Tikiz H, Baptiste RJ, Ayaz S, Sasmaz H, Korkmaz S. Circulating interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha, and soluble ICAM-1 in patients with chronic stable angina and myocardial infarction. Angiology 2001; 52: 109–14. 10.1177/000331970105200204Search in Google Scholar

6. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, et al. Elevated levels of interleukin-6 in unstable angina. Circulation 1996; 94: 874–7. 10.1161/01.CIR.94.5.874Search in Google Scholar

7. de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, Antman EM, et al. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 2003; 107: 690–5. 10.1161/01.CIR.0000049742.68848.99Search in Google Scholar

8. Marciniak A, Gierblinski I, Stefanski R, Lapinski M, Gaciong Z, Bartlomiejczyk I, et al. [Predictive value of plasma interleukin 1, interleukin 6, interleukin 8 and C-reactive protein (CRP) in patients with myocardial infarction]. Pol Arch Med Wewn 2003; 109: 15–22. Search in Google Scholar

9. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: 1767–72. 10.1161/01.CIR.101.15.1767Search in Google Scholar

10. Wang YN, Che SM, Ma AQ. Clinical significance of serum cytokines IL-1beta, sIL-2R, IL-6, TNF-alpha, and IFN-v in acute coronary syndrome. Chin Med Sci J 2004; 19: 120–4. Search in Google Scholar

11. Blankenberg S, Tiret L, Bickel C, Peetz D, Cambien F, Meyer J, et al. AtheroGene Investigators. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 2002; 106: 24–30. 10.1161/01.CIR.0000020546.30940.92Search in Google Scholar

12. Bach JF. Immunosuppressive therapy of autoimmune diseases. Immunol Today 1993; 14: 322–6. 10.1016/0167-5699(93)90053-NSearch in Google Scholar

13. Dai C, Liu Z, Zhou H, Li L. Monocyte chemoattractant protein-1 expression in renal tissue is associated with monocyte recruitment and tubulo-interstitial lesions in patients with lupus nephritis. Chin Med J (Engl) 2001; 114: 864–8. Search in Google Scholar

14. Nobili V, Marcellini M, Giovannelli L, Girolami E, Muratori F, Giannone G, et al. Association of serum interleukin-8 levels with the degree of fibrosis in infants with chronic liver disease. J Pediatr Gastroenterol Nutr 2004; 39: 540–4. 10.1097/00005176-200411000-00017Search in Google Scholar PubMed

15. Chen DY, Lan JL, Lin FJ, Hsieh TY. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease. J Rheumatol 2004; 31: 2189–98. Search in Google Scholar

16. Freire AL, Bertolo MB, de Pinho AJ Jr, Samara AM, Fernandes SR. Increased serum levels of interleukin-8 in polyarteritis nodosa and Behcet's disease. Clin Rheumatol 2004; 23: 203–5. 10.1007/s10067-003-0851-xSearch in Google Scholar PubMed

17. Grip O, Janciauskiene S, Lindgren S. Circulating monocytes and plasma inflammatory biomarkers in active Crohn's disease: elevated oxidized low-density lipoprotein and the anti-inflammatory effect of atorvastatin. Inflamm Bowel Dis 2004; 10: 193–200. 10.1097/00054725-200405000-00003Search in Google Scholar PubMed

18. Sun YX, Minthon L, Wallmark A, Warkentin S, Blennow K, Janciauskiene S. Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease. Dement Geriatr Cogn Disord 2003; 16: 136–44. 10.1159/000071001Search in Google Scholar PubMed

19. Jacobson SH, Egberg N, Hylander B, Lundahl J. Correlation between soluble markers of endothelial dysfunction in patients with renal failure. Am J Nephrol 2002; 22: 42–7. 10.1159/000046673Search in Google Scholar PubMed

20. de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, Antman EM, et al. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 2003; 107: 690–5. 10.1161/01.CIR.0000049742.68848.99Search in Google Scholar

21. Szodoray P, Alex P, Brun JG, Centola M, Jonsson R. Circulating cytokines in primary Sjogren's syndrome determined by a multiplex cytokine array system. Scand J Immunol 2004; 59: 592–9. 10.1111/j.0300-9475.2004.01432.xSearch in Google Scholar PubMed

22. Jarrard DF, Blitz BF, Smith RC, Patai BL, Rukstalis DB. Effect of epidermal growth factor on prostate cancer cell line PC3 growth and invasion. Prostate 1994; 24: 46–53. 10.1002/pros.2990240110Search in Google Scholar PubMed

23. Brzezinski J, Lewinski A. Increased plasma concentration of epidermal growth factor in female patients with non-toxic nodular goitre. Eur J Endocrinol 1998; 138: 388–93. 10.1530/eje.0.1380388Search in Google Scholar PubMed

24. Storkebaum E, Lambrechts D, Carmeliet P. VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 2004; 26: 943–54. 10.1002/bies.20092Search in Google Scholar PubMed

25. Li L, Wang L, Zhang W, Tang B, Zhang J, Song H, et al. Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer. Anticancer Res 2004; 24: 1973–9. Search in Google Scholar

26. Takano S, Yoshii Y, Kondo S, Suzuki H, Maruno T, Shirai S, et al. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res 1996; 56: 2185–90. Search in Google Scholar

27. Livshits G. Genetic epidemiology of skeletal system aging in apparently healthy human population. Mech Ageing Dev 2005; 126: 269–79. 10.1016/j.mad.2004.08.020Search in Google Scholar PubMed

28. Haddy N, Sass C, Maumus S, Marie B, Droesch S, Siest G, et al. Biological variations, genetic polymorphisms and familial resemblance of TNF-alpha and IL-6 concentrations: STANISLAS cohort. Eur J Hum Genet 2005; 13: 109–17. 10.1038/sj.ejhg.5201294Search in Google Scholar

29. Pantsulaia I, Trofimov S, Kobyliansky E, Livshits G. Genetic and environmental influences on IL-6 and TNF-alpha plasma levels in apparently healthy general population. Cytokine 2002; 19: 138–46. 10.1006/cyto.2002.1959Search in Google Scholar

30. Inadera H, Egashira K, Takemoto M, Ouchi Y, Matsushima K. Increase in circulating levels of monocyte chemoattractant protein-1 with aging. J Interferon Cytokine Res 1999; 19: 1179–82. 10.1089/107999099313127Search in Google Scholar

31. Tabara Y, Kohara K, Yamamoto Y, Igase M, Nakura J, Kondo I, et al. Polymorphism of the monocyte chemoattractant protein (MCP-1) gene is associated with the plasma level of MCP-1 but not with carotid intima-media thickness. Hypertens Res 2003; 26: 677–83. 10.1291/hypres.26.677Search in Google Scholar

32. Young DG, Skibinski G, Mason JI, James K. The influence of age and gender on serum dehydroepiandrosterone sulphate (DHEA-S), IL-6, IL-6 soluble receptor (IL-6 sR) and transforming growth factor beta 1 (TGF-beta1) levels in normal healthy blood donors. Clin Exp Immunol 1999; 117: 476–81. 10.1046/j.1365-2249.1999.01003.xSearch in Google Scholar

33. Malamitsi-Puchner A, Tziotis J, Tsonou A, Protonotariou E, Sarandakou A, Creatsas G. Changes in serum levels of vascular endothelial growth factor in males and females throughout life. J Soc Gynecol Invest 2000; 7: 309–12. 10.1016/S1071-5576(00)00073-3Search in Google Scholar

34. Yeager MP, Guyre PM, Munck AU. Glucocorticoid regulation of the inflammatory response to injury. Acta Anaesthesiol Scand 2004; 48: 799–813. 10.1111/j.1399-6576.2004.00434.xSearch in Google Scholar PubMed

35. Vicennati V, Vottero A, Friedman C, Papanicolaou DA. Hormonal regulation of interleukin-6 production in human adipocytes. Int J Obes Relat Metab Disord 2002; 26: 905–11. 10.1038/sj.ijo.0802035Search in Google Scholar PubMed

36. Arias J, Melean E, Valero N, Pons H, Chacin-Bonilla L, Larreal Y, et al. Effect of melatonin on lymphocyte proliferation and production of interleukin-2 (IL-2) and interleukin-1 beta (IL-1 beta) in mice splenocytes. Invest Clin 2003; 44: 41–50. Search in Google Scholar

37. Corwin EJ, Cannon JG. Gonadotropin modulation of interleukin-1 secretion. J Gend Specif Med 1999; 2: 30–4. Search in Google Scholar

38. Burger D, Dayer JM. Cytokines, acute-phase proteins, and hormones: IL-1 and TNF-alpha production in contact-mediated activation of monocytes by T lymphocytes. Ann NY Acad Sci 2002; 966: 464–73. 10.1111/j.1749-6632.2002.tb04248.xSearch in Google Scholar PubMed

39. Morishita M, Miyagi M, Iwamoto Y. Effects of sex hormones on production of interleukin-1 by human peripheral monocytes. J Periodontol 1999; 70: 757–60. 10.1902/jop.1999.70.7.757Search in Google Scholar PubMed

40. Lebovic DI, Shifren JL, Ryan IP, Mueller MD, Korn AP, Darney PD, et al. Ovarian steroid and cytokine modulation of human endometrial angiogenesis. Hum Reprod 2000; 15(Suppl): 67–77. 10.1093/humrep/15.suppl_3.67Search in Google Scholar

41. Ray A, Prefontaine KE, Ray P. Down-modulation of interleukin-6 gene expression by 17-beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J Biol Chem 1994; 269: 12940–6. 10.1016/S0021-9258(18)99966-7Search in Google Scholar

42. Deguchi K, Kamada M, Irahara M, Maegawa M, Yamamoto S, Ohmoto Y, et al. Postmenopausal changes in production of type 1 and type 2 cytokines and the effects of hormone replacement therapy. Menopause 2001; 8: 266–73. 10.1097/00042192-200107000-00008Search in Google Scholar

43. Elenkov IJ, Chrousos GP. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann NY Acad Sci 2002; 966: 290–303. 10.1111/j.1749-6632.2002.tb04229.xSearch in Google Scholar

44. Ouyang Y, Virasch N, Hao P, Aubrey MT, Mukerjee N, Bierer BE, et al. Suppression of human IL-1beta, IL-2, IFN-gamma, and TNF-alpha production by cigarette smoke extracts. J Allergy Clin Immunol 2000; 106: 280–7. 10.1067/mai.2000.107751Search in Google Scholar

45. McKay A, Komai-Koma M, MacLeod KJ, Campbell CC, Kitson SM, Chaudhuri R, et al. Interleukin-18 levels in induced sputum are reduced in asthmatic and normal smokers. Clin Exp Allergy 2004; 34: 904–10. 10.1111/j.1365-2222.2004.01973.xSearch in Google Scholar

46. Burgess JL, Nanson CJ, Hysong TA, Gerkin R, Witten ML, Lantz RC. Rapid decline in sputum IL-10 concentration following occupational smoke exposure. Inhal Toxicol 2002; 14: 133–40. 10.1080/089583701753403953Search in Google Scholar

47. de Maat MP, Kluft C. The association between inflammation markers, coronary artery disease and smoking. Vascul Pharmacol 2002; 39: 137–9. 10.1016/S1537-1891(02)00301-4Search in Google Scholar

48. Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 2002; 22: 1668–73. 10.1161/01.ATV.0000029781.31325.66Search in Google Scholar PubMed

49. Deo R, Khera A, McGuire DK, Murphy SA, Meo Neto J de P, Morrow DA, et al. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J Am Coll Cardiol 2004; 44: 1812–8. 10.1016/j.jacc.2004.07.047Search in Google Scholar PubMed

50. Steptoe A, Willemsen G, Owen N, Flower L, Mohamed-Ali V. Acute mental stress elicits delayed increases in circulating inflammatory cytokine levels. Clin Sci (Lond) 2001; 101: 185–92. 10.1042/CS20010038Search in Google Scholar

51. Paik IH, Toh KY, Lee C, Kim JJ, Lee SJ. Psychological stress may induce increased humoral and decreased cellular immunity. Behav Med 2000; 26: 139–41. 10.1080/08964280009595761Search in Google Scholar

52. Glaser R, MacCallum RC, Laskowski BF, Malarkey WB, Sheridan JF, Kiecolt-Glaser JK. Evidence for a shift in the Th-1 to Th-2 cytokine response associated with chronic stress and aging. J Gerontol A Biol Sci Med Sci 2001; 56: M477–82. 10.1093/gerona/56.8.M477Search in Google Scholar

53. Suzuki K, Nakaji S, Yamada M, Totsuka M, Sato K, Sugawara K. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Exerc Immunol Rev 2002; 8: 6–48. Search in Google Scholar

54. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82: 4196–200. Search in Google Scholar

55. Nappo F, Esposito K, Cioffi M, Giugliano G, Molinari AM, Paolisso G, et al. Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol 2002; 39: 1145–50. 10.1016/S0735-1097(02)01741-2Search in Google Scholar

56. Straczkowski M, Dzienis-Straczkowska S, Stepien A, Kowalska I, Szelachowska M, Kinalska I. Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system. J Clin Endocrinol Metab 2002; 87: 4602–6. 10.1210/jc.2002-020135Search in Google Scholar PubMed

57. Escobar-Morreale HF, Botella-Carretero JI, Villuendas G, Sancho J, San Millan JL. Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity. J Clin Endocrinol Metab 2004; 89: 806–11. 10.1210/jc.2003-031365Search in Google Scholar PubMed

58. Corica F, Allegra A, Buemi M, Corsonello A, Bonanzinga S, Rubino F, et al. Reduced plasma concentrations of transforming growth factor beta1 (TGF-beta1) in obese women. Int J Obes Relat Metab Disord 1997; 21: 704–7. 10.1038/sj.ijo.0800465Search in Google Scholar PubMed

59. de Craen AJ, Posthuma D, Remarque EJ, van den Biggelaar AH, Westendorp RG, Boomsma DI. Heritability estimates of innate immunity: an extended twin study. Genes Immun 2005; 6: 167–70. 10.1038/sj.gene.6364162Search in Google Scholar PubMed

60. Pantsulaia I, Trofimov S, Kobyliansky E, Livshits G. Genetic and environmental influences on IL-6 and TNF-alpha plasma levels in apparently healthy general population. Cytokine 2002; 19: 138–46. 10.1006/cyto.2002.1959Search in Google Scholar PubMed

61. Reuss E, Fimmers R, Kruger A, Becker C, Rittner C, Hohler T. Differential regulation of interleukin-10 production by genetic and environmental factors – a twin study. Genes Immun 2002; 3: 407–13. 10.1038/sj.gene.6363920Search in Google Scholar PubMed

62. Pantsulaia I, Trofimov S, Kobyliansky E, Livshits G. Heritability of circulating growth factors involved in the angiogenesis in healthy human population. Cytokine 2004; 27: 152–8. 10.1016/j.cyto.2004.04.005Search in Google Scholar

63. Harrela M, Koistinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J, et al. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest 1996; 98: 2612–5. 10.1172/JCI119081Search in Google Scholar

64. Pantsulaia I, Malkin I, Trofimov S, Kobyliansky E, Livshits G. Genetic regulation of the variation of circulating variation of insulin-like growth factors and leptin in human pedigrees. Submitted for publication. Search in Google Scholar

65. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999; 8: 93–7. 10.1093/hmg/8.1.93Search in Google Scholar

66. Pantsulaia I, Trofimov S, Kalichman L, Kobyliansky E, Livshits G. The contribution of familial resemblance to variation in circulatory levels of tissue inhibitors of metalloproteinases and transforming growth factor-beta1. Calcif Tissue Int 2004; 74: 47–54. 10.1007/s00223-003-0046-0Search in Google Scholar

67. Bailly S, Israel N, Fay M, Gougerot-Pocidalo MA, Duff GW. An intronic polymorphic repeat sequence modulates interleukin-1 alpha gene regulation. Mol Immunol 1996; 33: 999–1006. 10.1016/S0161-5890(96)00042-9Search in Google Scholar

68. Hamajima N, Katsuda N, Matsuo K, Saito T, Ito LS, Ando M, et al. Smoking habit and interleukin 1B C-31T polymorphism. J Epidemiol 2001; 11: 120–5. 10.2188/jea.11.120Search in Google Scholar PubMed

69. Hoffmann SC, Stanley EM, Darrin CE, Craighead N, DiMercurio BS, Koziol DE, et al. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes. Transplantation 2001; 72: 1444–50. 10.1097/00007890-200110270-00019Search in Google Scholar PubMed

70. Hull J, Thomson A, Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the inter-leukin 8 gene region in UK families. Thorax 2000; 55: 1023–7. 10.1136/thorax.55.12.1023Search in Google Scholar PubMed PubMed Central

71. Rovin BH, Lu L, Zhang X. A novel interleukin-8 polymorphism is associated with severe systemic lupus erythematosus nephritis. Kidney Int 2002; 62: 261–5. 10.1046/j.1523-1755.2002.00438.xSearch in Google Scholar PubMed

72. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1–8. 10.1111/j.1365-2370.1997.tb00001.xSearch in Google Scholar PubMed

73. Rosenwasser LJ, Borish L. Genetics of atopy and asthma: the rationale behind promoter-based candidate gene studies (IL-4 and IL-10). Am J Respir Crit Care Med 1997; 156: S152–5. 10.1164/ajrccm.156.4.12tac-14Search in Google Scholar

74. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999; 42: 1101–8. 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-YSearch in Google Scholar

75. Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alpha. Hepatology 1999; 30: 526–30. 10.1002/hep.510300207Search in Google Scholar

76. Giedraitis V, He B, Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 2001; 112: 146–52. 10.1016/S0165-5728(00)00407-0Search in Google Scholar

77. Bream JH, Ping A, Zhang X, Winkler C, Young HA. A single nucleotide polymorphism in the proximal IFN-gamma promoter alters control of gene transcription. Genes Immun 2002; 3: 165–9. 10.1038/sj.gene.6363870Search in Google Scholar

78. Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 2000; 61: 863–6. 10.1016/S0198-8859(00)00167-1Search in Google Scholar

79. Skoog T, van't Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J, et al. A common functional polymorphism (C→A substitution at position –863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 1999; 8: 1443–9. 10.1093/hmg/8.8.1443Search in Google Scholar

80. Uglialoro AM, Turbay D, Pesavento PA, Delgado JC, McKenzie FE, Gribben JG, et al. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. Tissue Antigens 1998; 52: 359–67. 10.1111/j.1399-0039.1998.tb03056.xSearch in Google Scholar

81. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, Roland S, et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998; 113: 401–6. 10.1046/j.1365-2249.1998.00662.xSearch in Google Scholar

82. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195–9. 10.1073/pnas.94.7.3195Search in Google Scholar

83. Bayley JP, de Rooij H, van den Elsen PJ, Huizinga TW, Verweij CL. Functional analysis of linker-scan mutants spanning the –376, –308, –244, and –238 polymorphic sites of the TNF-alpha promoter. Cytokine 2001; 14: 316–23. 10.1006/cyto.2001.0902Search in Google Scholar

84. Brinkman BM, Zuijdeest D, Kaijzel EL, Breedveld FC, Verweij CL. Relevance of the tumor necrosis factor alpha (TNF alpha) –308 promoter polymorphism in TNF alpha gene regulation. J Inflamm 1995–96; 46: 32–41. Search in Google Scholar

85. Fong CL, Mark DF. The NF-kappa B-like site in the TNF-alpha repressor element is essential for its repressor function. Biochem Biophys Res Commun 1995; 212: 879–86. 10.1006/bbrc.1995.2051Search in Google Scholar

86. Grove J, Daly AK, Bassendine MF, Day CP. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology 1997; 26: 143–6. 10.1002/hep.510260119Search in Google Scholar

87. Messer G, Spengler U, Jung MC, Honold G, Blomer K, Pape GR, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 1991; 173: 209–19. 10.1084/jem.173.1.209Search in Google Scholar

88. Koch W, Kastrati A, Bottiger C, Mehilli J, von Beckerath N, Schomig A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 2001; 159: 137–44. 10.1016/S0021-9150(01)00467-1Search in Google Scholar

89. Warzocha K, Ribeiro P, Bienvenu J, Roy P, Charlot C, Rigal D, et al. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood 1998; 91: 3574–81. 10.1182/blood.V91.10.3574Search in Google Scholar

90. Shahbazi M, Pravica V, Nasreen N, Fakhoury H, Fryer AA, Strange RC, et al. Association between functional polymorphism in EGF gene and malignant melanoma. Lancet 2002; 359: 397–401. 10.1016/S0140-6736(02)07600-6Search in Google Scholar

91. Rosen CJ, Kurland ES, Vereault D, Adler RA, Rackoff PJ, Craig WY, et al. Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. J Clin Endocrinol Metab 1998; 83: 2286–90. 10.1210/jcem.83.7.4964Search in Google Scholar PubMed

92. Schut AF, Janssen JA, Deinum J, Vergeer JM, Hofman A, Lamberts SW, et al. Polymorphism in the promoter region of the insulin-like growth factor I gene is related to carotid intima-media thickness and aortic pulse wave velocity in subjects with hypertension. Stroke 2003; 34: 1623–7. 10.1161/01.STR.0000076013.00240.B0Search in Google Scholar PubMed

93. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999; 8: 93–7. 10.1093/hmg/8.1.93Search in Google Scholar PubMed

94. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000; 12: 1232–5. 10.1006/cyto.2000.0692Search in Google Scholar

95. Koukourakis MI, Papazoglou D, Giatromanolaki A, Bougioukas G, Maltezos E, Siviridis E. VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer 2004; 46: 293–8. 10.1016/j.lungcan.2004.04.037Search in Google Scholar

96. Rovin BH, Lu L, Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 1999; 259: 344–8. 10.1006/bbrc.1999.0796Search in Google Scholar

97. Rundek T, Elkind MS, Pittman J, Boden-Albala B, Martin S, Humphries SE, et al. Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study. Stroke 2002; 33: 1420–3. 10.1161/01.STR.0000015558.63492.B6Search in Google Scholar

98. Flex A, Gaetani E, Pola R, Santoliquido A, Aloi F, Papaleo P, et al. The –174 G/C polymorphism of the interleukin-6 gene promoter is associated with peripheral artery occlusive disease. Eur J Vasc Endovasc Surg 2002; 24: 264–8. 10.1053/ejvs.2002.1711Search in Google Scholar

99. Weger M, Steinbrugger I, Haas A, Marz W, El-Shabrawi Y, Weger W, et al. Role of the interleukin-6 –174 G→C gene polymorphism in retinal artery occlusion. Stroke 2005; 36: 249–52. 10.1161/01.STR.0000151329.84830.37Search in Google Scholar

100. Szalai C, Duba J, Prohaszka Z, Kalina A, Szabo T, Nagy B, et al. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 –2518 G/G genotype in CAD patients. Atherosclerosis 2001; 158: 233–9. 10.1016/S0021-9150(01)00423-3Search in Google Scholar

101. Andreotti F, Porto I, Crea F, Maseri A. Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies. Heart 2002; 87: 107–12. 10.1136/heart.87.2.107Search in Google Scholar PubMed PubMed Central

102. Auer J, Weber T, Berent R, Lassnig E, Lamm G, Eber B. Genetic polymorphisms in cytokine and adhesion molecule genes in coronary artery disease. Am J Pharmacogenomics 2003; 3: 317–28. 10.2165/00129785-200303050-00003Search in Google Scholar PubMed

103. Stephens JW, Humphries SE. The molecular genetics of cardiovascular disease: clinical implications. J Intern Med 2003; 253: 120–7. 10.1046/j.1365-2796.2003.01104.xSearch in Google Scholar PubMed

104. Padovani JC, Pazin-Filho A, Simoes MV, Marin-Neto JA, Zago MA, Franco RF. Gene polymorphisms in the TNF locus and the risk of myocardial infarction. Thromb Res 2000; 100: 263–9. 10.1016/S0049-3848(00)00315-7Search in Google Scholar

105. Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ. The interleukin-6 –174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 2001; 22: 2243–52. 10.1053/euhj.2001.2678Search in Google Scholar

106. Jerrard-Dunne P, Sitzer M, Risley P, Buehler A, von Kegler S, Markus HS. Inflammatory gene load is associated with enhanced inflammation and early carotid atherosclerosis in smokers. Stroke 2004; 35: 2438–43. 10.1161/01.STR.0000144681.46696.b3Search in Google Scholar

107. Fitzpatrick DR, Wilson CB. Methylation and demethylation in the regulation of genes, cells, and responses in the immune system. Clin Immunol 2003; 109: 37–45. 10.1016/S1521-6616(03)00205-5Search in Google Scholar

108. Bayley JP, Bakker AM, Kaijzel EL, Wierenga EA, van der Pouw-Kraan TC, Huizinga TW, et al. Analysis of allelic expression patterns of IL-2, IL-3, IL-4 and IL-13 in human CD4 + T cell clones. Eur J Immunol 2003; 33: 2142–8. 10.1002/eji.200323976Search in Google Scholar

109. Bayley JP, van Rietschoten JG, Bakker AM, van Baarsen L, Kaijzel EL, Wierenga EA, et al. Allele-specific expression of the IL-1alpha gene in human CD4+ T cell clones. J Immunol 2003; 171: 2349–53. 10.4049/jimmunol.171.5.2349Search in Google Scholar

110. Matesanz F, Delgado C, Fresno M, Alcina A. Allelic selection of human IL-2 gene. Eur J Immunol 2000; 30: 3516–21. 10.1002/1521-4141(2000012)30:12<3516::AID-IMMU3516>3.0.CO;2-SSearch in Google Scholar

111. Siest G, Visvikis S, Herbeth B, Gueguen R, Vincent-Viry M, Sass C, et al. Objectives, design and recruitment of a familial and longitudinal cohort for studying gene-environment interactions in the field of cardiovas-cular risk: the Stanislas cohort. Clin Chem Lab Med 1998; 36: 35–42. 10.1515/CCLM.1998.007Search in Google Scholar

112. Victor RG, Haley RW, Willett DL, Peshock RM, Vaeth PC, Leonard D, Basit M, Cooper RS, Iannacchione VG, Visscher WA, Staab JM, Hobbs HH. Dallas Heart Study Investigators. The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol 2004; 93: 1473–1480. 10.1016/j.amjcard.2004.02.058Search in Google Scholar

113. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 1991; 7: 403–22. 10.1007/BF00145007Search in Google Scholar